Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Howie

Showing results (281-290 of 295) with videos related to

Pageof 30
Sort By:
Clinical Breast Cancer|April 5, 2018
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive PhenotypeJeremy Force, Lynn J Howie, Sara E Abbott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2018
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast CancerLynn J Howie, Nancy S Scher, Laleh Amiri-Kordestani, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2010
KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel functionMarkus Reichold, Anselm A Zdebik, Evelyn Lieberer, et al.
Clinical and Translational Allergy|August 9, 2025
Benralizumab Depletes IL-5Rα-Bearing Cells in Skin Lesions of Patients With Atopic DermatitisChristiane E Whetstone, Ruth P Cusack, Emma L Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2019
Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled AnalysisLynn J Howie, Harpreet Singh, Erik Bloomquist, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2010
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthmaGail M Gauvreau, Louis-Philippe Boulet, Donald W Cockcroft, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2009
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)Agnes B Fogo, Leif Bostad, Einar Svarstad, et al.
JCI Insight|January 6, 2022
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humansMangalakumari Jeyanathan, Dominik K Fritz, Sam Afkhami, et al.
Nature Communications|July 2, 2025
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trialMangalakumari Jeyanathan, Sam Afkhami, Michael R D'Agostino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Predictors of renal outcome in HIV-associated nephropathyFrank A Post, Lucy J Campbell, Lisa Hamzah, et al.
Pageof 30

Showing results (281-290 of 295) with videos related to

Sort By:
Pageof 30
Clinical Breast Cancer|April 5, 2018
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive PhenotypeJeremy Force, Lynn J Howie, Sara E Abbott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2018
FDA Approval Summary: Pertuzumab for Adjuvant Treatment of HER2-Positive Early Breast CancerLynn J Howie, Nancy S Scher, Laleh Amiri-Kordestani, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2010
KCNJ10 gene mutations causing EAST syndrome (epilepsy, ataxia, sensorineural deafness, and tubulopathy) disrupt channel functionMarkus Reichold, Anselm A Zdebik, Evelyn Lieberer, et al.
Clinical and Translational Allergy|August 9, 2025
Benralizumab Depletes IL-5Rα-Bearing Cells in Skin Lesions of Patients With Atopic DermatitisChristiane E Whetstone, Ruth P Cusack, Emma L Price, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2019
Outcomes of Older Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled AnalysisLynn J Howie, Harpreet Singh, Erik Bloomquist, et al.
American Journal of Respiratory and Critical Care Medicine|November 9, 2010
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthmaGail M Gauvreau, Louis-Philippe Boulet, Donald W Cockcroft, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 17, 2009
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN)Agnes B Fogo, Leif Bostad, Einar Svarstad, et al.
JCI Insight|January 6, 2022
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humansMangalakumari Jeyanathan, Dominik K Fritz, Sam Afkhami, et al.
Nature Communications|July 2, 2025
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trialMangalakumari Jeyanathan, Sam Afkhami, Michael R D'Agostino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Predictors of renal outcome in HIV-associated nephropathyFrank A Post, Lucy J Campbell, Lisa Hamzah, et al.
Pageof 30